Please login to the form below

Not currently logged in

Pharmaceutical Market Europe - September 2012

PME Sept 2012

PME - September 2012. This issue PME talks to …

Cavan Redmond 

Cavan chats about his move from Pfizer to WebMD and the important lessons pharma can learn about engagement from its consumer contemporaries

And we take a look at …

Value of medicines

David Coleiro, Paula Lashley and John Grime of Strategic North ask if we are obscuring the true value of medicines with our intense focus on cost


Marc Martens and Nicolas Carbonnelle from Bird & Bird look at the impact of new European pharmacovigilance legislation on the industry

Game software 

Clinical trials of game-like software designed to re-programme the brain and tackle some of the most intractable symptoms of schizophrenia could usher in a new way to treat a range of neurological diseases

Iconic brands 

Wes Wilkes of Interbrand Health takes us through the six characteristics that make a strong healthcare brand

View: September 2012 PME online 

Also with this issue …

… Emerging Markets Guide 

Investment is the key theme running through the guide, which explores all 17 ‘pharmerging’ markets (as dubbed by IMS) and forecasts their performance over the coming five years. That China is stealing a march on its fellow emerging markets is nothing new, but among the other 16 nations, there are some surprises.

Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.

PME is also available to download as an app for iPhone and iPad

Featured jobs

Subscribe to our email news alerts


Add my company

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...